Reported Dec 24, 2014 · Terminated
Benzonatate Capsules, USP, 200 mg, 100-count bottles, Rx only, Manufactured by
Zydus Pharmaceuticals USA Inc.
Moderate riskThis product could cause temporary or reversible health problems — stop using it.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: Zydus Pharmaceuticals USA Inc · 73 Route 31 N · Pennington, NJ · 08534-3601
Is this the product you have?
Benzonatate Capsules, USP, 200 mg, 100-count bottles, Rx only, Manufactured by
3 of 3 products
| # | Product as published |
|---|---|
| 1 | Cadila Healthcare Ltd, Ahmedabad, India |
| 2 | Distributed by: Zydus Pharmaceuticals USA, In, Pennington, NJ USA 08534 |
| 3 | NDC 68382-248-01, UPC 3 68382 24801 5. |
- Lot codes and dates
Lot #: MP2137MP2138MP2139Exp 01/16MP3614Exp 03/16MP5611MP5613Exp 05/16
- Amount recalled
- 58,920 bottles
Where it was sold
- Nationwide
- PR
Why it was recalled
Failed Tablet/Capsule Specifications: Recall due to wet and/or leaking capsules.
This product could cause temporary or reversible health problems — stop using it.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Zydus Pharmaceuticals USA Inc. recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.